After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Recently, Yahoo Finance discussed the stock, revealing that Halozyme to Participate in Upcoming Investor Conferences.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Halozyme Therapeutics Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Halozyme Therapeutics Inc. is $5.29B. A total of 1.03 million shares were traded on the day, compared to an average of 1.39M shares.
In the most recent transaction, LaBarre Michael J. sold 10,000 shares of HALO for 39.55 per share on Feb 28 ’24. After the transaction, the SVP, CHIEF TECHNICAL OFFICER now owns 156,558 company shares. In a previous transaction on Feb 27 ’24, LaBarre Michael J. sold 10,000 shares at 39.95 per share. HALO shares that SVP, CHIEF TECHNICAL OFFICER owns now total 159,087.
Among the insiders who sold shares, LaBarre Michael J. disposed of 10,000 shares on Jan 17 ’24 at a per-share price of $36.00. This resulted in the SVP, CHIEF TECHNICAL OFFICER holding 151,911 shares of HALO after the transaction. In another insider transaction, LaBarre Michael J. sold 10,000 shares at $36.00 per share on Jan 16 ’24. Company shares held by the SVP, CHIEF TECHNICAL OFFICER now total 151,911.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, HALO has a high of $46.32 and a low of $29.85.
As of this writing, HALO has an earnings estimate of $0.76 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of $0.83 per share and a lower estimate of $0.69. The company reported an EPS of $0.75 in the last quarter, which was 5.60% higher than expectations of $0.71.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. HALO’s latest balance sheet shows that the firm has $740.92M in Cash & Short Term Investments as of fiscal 2021. There were $876.67M in debt and $117.15M in liabilities at the time. Its Book Value Per Share was $0.66, while its Total Shareholder’s Equity was $196.95M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HALO is Buy with a score of 4.60.
